Fox Run Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-124
Closed -$173K 753
2017
Q3
$173K Buy
+124
New +$173K 0.05% 620